Clinical Trial Update: Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating MK0767 in combination with Metformin for Type 2 diabetes has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MK0767
• metformin (metformin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: TERMINATED